Compile Data Set for Download or QSAR

Found 60 hits of Enzyme Inhibition Constant Data   

TargetEstrogen receptor beta(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50084948(CHEMBL195515 | GW7604)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-beta (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50084948(CHEMBL195515 | GW7604)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-alpha (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 6.10nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-alpha (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor beta(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 8.80nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-beta (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor beta(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50169743((13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pe...)copy SMILEScopy InChI
Affinity DataIC50: 21nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-beta (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50169743((13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pe...)copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-alpha (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM19442(2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)p...)copy SMILEScopy InChI
Affinity DataIC50: 42nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-alpha (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor beta(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM19442(2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)p...)copy SMILEScopy InChI
Affinity DataIC50: 240nMAssay Description:Displacement of [3H]-E2 from estrogen receptor-beta (unknown origin) by scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetGlucocorticoid receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 990nMAssay Description:Binding affinity to glucocorticoid receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetProgesterone receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at progesterone-A receptor (unknown origin) by transcriptional reporter assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetProgesterone receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at progesterone-B receptor (unknown origin) by transcriptional reporter assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetMineralocorticoid receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at mineralocorticoid receptor (unknown origin) by transcriptional reporter assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetGlucocorticoid receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at glucocorticoid receptor (unknown origin) by transcriptional reporter assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of dopamine transporter (unknown origin) by cell-based assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetAndrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 4.00E+3nMAssay Description:Binding affinity to androgen receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090456(CHEMBL3581687)copy SMILEScopy InChI
Affinity DataEC50:  36nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090461(CHEMBL3581692)copy SMILEScopy InChI
Affinity DataEC50:  0.900nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090467(CHEMBL3581637)copy SMILEScopy InChI
Affinity DataEC50:  23nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090299(CHEMBL3581681)copy SMILEScopy InChI
Affinity DataEC50:  0.5nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090451(CHEMBL3581682)copy SMILEScopy InChI
Affinity DataEC50:  0.700nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090219(CHEMBL3581643)copy SMILEScopy InChI
Affinity DataEC50:  15nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090255(CHEMBL3581675)copy SMILEScopy InChI
Affinity DataEC50:  110nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090458(CHEMBL3581689)copy SMILEScopy InChI
Affinity DataEC50:  49nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50041611((2E)-3-{4-[(1E)-1,2-DIPHENYLBUT-1-ENYL]PHENYL}ACRY...)copy SMILEScopy InChI
Affinity DataEC50:  390nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50084948(CHEMBL195515 | GW7604)copy SMILEScopy InChI
Affinity DataEC50:  1.70nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090466(CHEMBL3581636)copy SMILEScopy InChI
Affinity DataEC50:  101nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090468(CHEMBL3581638)copy SMILEScopy InChI
Affinity DataEC50:  3nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090221(CHEMBL3581644)copy SMILEScopy InChI
Affinity DataEC50:  6nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090265(CHEMBL3581676)copy SMILEScopy InChI
Affinity DataEC50:  1.13E+3nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090453(CHEMBL3581684)copy SMILEScopy InChI
Affinity DataEC50:  10nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090454(CHEMBL3581685)copy SMILEScopy InChI
Affinity DataEC50:  3nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090459(CHEMBL3581690)copy SMILEScopy InChI
Affinity DataEC50:  4nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090455(CHEMBL3581686)copy SMILEScopy InChI
Affinity DataEC50:  28nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090268(CHEMBL3581678)copy SMILEScopy InChI
Affinity DataEC50:  8nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090187(CHEMBL3581642)copy SMILEScopy InChI
Affinity DataEC50:  357nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090469(CHEMBL3581639)copy SMILEScopy InChI
Affinity DataEC50:  957nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090465(CHEMBL3581635)copy SMILEScopy InChI
Affinity DataEC50:  1.05E+3nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090233(CHEMBL3581646)copy SMILEScopy InChI
Affinity DataEC50:  11nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090464(CHEMBL3581634)copy SMILEScopy InChI
Affinity DataEC50:  6.28E+3nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM19442(2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)p...)copy SMILEScopy InChI
Affinity DataEC50:  0.200nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099587(2-(4-Hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-...)copy SMILEScopy InChI
Affinity DataEC50:  0.100nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50169743((13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pe...)copy SMILEScopy InChI
Affinity DataEC50:  0.400nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090270(CHEMBL3581680)copy SMILEScopy InChI
Affinity DataEC50:  2nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
TargetEstrogen receptor(Homo sapiens (Human))
Seragon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090463(CHEMBL3581633)copy SMILEScopy InChI
Affinity DataEC50:  113nMAssay Description:Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H7QPubMed
Displayed 1 to 50 (of 60 total ) | Next | Last >>* indicates data uncertainty>20%